@
placement:
NameDescriptionContent
Product Showcase
Olmesartan Medoxomil
    Publish time 2024-09-19 10:05    

CAS NO.: 144689-63-4

Olmesartan Medoxomil

Olmesartan Medoxomil

Basic Information

  • English Name: Olmesartan Medoxomil

  • Chinese Alias: 美沙坦酯

  • CAS Number: 144689-63-4

  • Molecular Formula: C29H30N6O6 (Note: The exact molecular weight may vary slightly in different sources, but is close to 558.59)

  • Appearance: Typically a pale yellow to off-white or white to grayish-white crystalline powder

Pharmacological Action

  • Olmesartan Medoxomil is a prodrug that, upon absorption in the gastrointestinal tract, is hydrolyzed to Olmesartan, which is a selective angiotensin II type 1 receptor (AT1) antagonist.

  • It blocks the binding of angiotensin II to the AT1 receptor on vascular smooth muscle, thereby inhibiting the vasoconstrictive effects of angiotensin II and achieving a reduction in blood pressure.

  • The hypotensive effect of Olmesartan Medoxomil is independent of the angiotensin II synthetic pathway and does not affect the degradation of bradykinin.

Clinical Applications

  • Olmesartan Medoxomil is primarily used for the treatment of hypertension, demonstrating efficacy across various types of hypertension.

  • Its notable features include a long half-life, allowing for effective blood pressure control over 24 hours with convenient dosing.

  • Compared to other angiotensin II receptor antagonists, Olmesartan Medoxomil offers advantages such as a smaller dose, faster onset, stronger and longer-lasting hypotensive effects, and a lower incidence of adverse reactions.

  • Additionally, Olmesartan Medoxomil exhibits beneficial effects on atherosclerosis, myocardial hypertrophy, heart failure, diabetes, nephropathy, among others.

Drug Interactions

  • Olmesartan Medoxomil is not metabolized by hepatic cytochrome P450 enzymes and does not affect P450 enzyme activity, thus avoiding drug interactions related to inhibition, induction, or metabolism of these enzymes.

  • No significant drug interactions were observed when Olmesartan Medoxomil was co-administered with digoxin or warfarin in healthy subjects.

Storage and Transportation

  • Olmesartan Medoxomil should be stored at -20°C to ensure stability and efficacy.

  • During transportation, measures such as ultra-low temperature ice packs should be used to maintain the low-temperature environment.